Oct 19, 2026, 11:10 by

The recognition highlights Clinion’s work applying governed, multi-agent AI to clinical data management and study intelligence.

Oct 19, 2026, 11:10 by

First clinical results show Panther's microarray patch was well tolerated across eight applications over four weeks, with an efficacy study planned for later this year.

Oct 19, 2026, 11:10 by

WeGuide has been awarded A$1.9 million in CUREator+ funding to build a platform that makes commercial digital biomarker development faster and cheaper, starting with a mobility recovery biomarker with NeuRA.

Oct 19, 2026, 11:10 by

Paradigm Clinical Research, Inc., a clinical research site organization, opens a clinical trial site in Las Vegas, marking the company’s ninth site location and expanding its geographic reach into one of the West’s largest and most diverse communities.

Oct 15, 2026, 01:00 by User Not Found

Clinical Research News | A startup precision medicine management company is “cracking the code” on how to make cutting-edge treatments more accessible to patients and at the same time financially sustainable for all stakeholders. The approach of 3-year-old Medzown collapses the boundaries between clinical care and clinical trials to create a unified care pathway, according to founder and CEO Jennifer Levin Carter, M.D.

Oct 13, 2026, 01:00 by User Not Found

Clinical Research News | The latest episode of the Scope of Things podcast shares a conversation between Michelle Snyder of McKesson and Synapticure CEO Sandra Abravaya as they follow Abravaya’s path from public service to healthcare entrepreneurship, grounded in an ALS caregiver’s view of what happens when guidance is unavailable at the moment it matters most.

Oct 9, 2026, 12:43 by

• Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College London) to lead event taking place from 10–11 November at GSK Stevenage • Programme to focus on AI, machine learning and data-driven approaches across protein design, characterisation and therapeutic development

Oct 8, 2026, 09:28 by

Oct 8, 2026, 09:27 by

Oct 8, 2026, 01:01 by User Not Found

Clinical Research NewsBrain organoids, three-dimensional tissues grown from stem cells, are edging closer to the clinic, with researchers envisioning a future in which a patient's response to a drug can be tested in a lab dish before they ever enroll in a study.

Oct 6, 2026, 11:51 by

CellCarta today announced a strategic partnership with Waters Corporation creating a framework to jointly pursue companion diagnostic and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.

Oct 6, 2026, 11:50 by

Upperton has unveiled a new brand identity at CPHI Milan, marking a significant milestone in the company's evolution into a specialist, end-to-end contract development and manufacturing organisation (CDMO) focused on solving the challenges of molecule development across oral, nasal, pulmonary and parenteral dosage forms.

Oct 6, 2026, 11:50 by

CluePoints sponsored RBQMLive 2026 will explore shift from adoption to operational maturity.

Oct 6, 2026, 01:01 by User Not Found

Clinical Research NewsToday, RBQM offers not just regulatory compliance but the ability to add measurable value to drug development and sponsor organizations. However, many organizations are still operating with fragmented tools, static risk registers and reactive monitoring models. To unlock the true power of RBQM, the industry needs to embrace its potential as a live, operational oversight model.

Oct 2, 2026, 11:54 by

CellCarta and Imagene AI today announced an expanded collaboration to provide a coordinated path for biopharma companies to validate, deploy, and scale AI-powered biomarker and companion diagnostic programs.

Oct 2, 2026, 11:53 by

Advarra today announced the launch of its new Site ID technology.

Oct 2, 2026, 11:53 by

Pre-conference workshop on the future of AI in pharmacometrics and four scientific poster presentations highlight PumasAI’s presence at the American Conference on Pharmacometrics (ACoP)

Oct 2, 2026, 11:53 by

Oct 2, 2026, 11:52 by

Oct 2, 2026, 11:52 by

Ceryx Medical has appointed Professor Zaheer Yousef OBE as Chief Medical Officer. Professor Yousef is a consultant cardiologist at the University Hospital of Wales and was principal investigator on RSA-Pace, Ceryx's multi-centre study of its respiratory sinus arrhythmia pacing technology. He joins as the company moves towards a clinical study designed to demonstrate the full clinical benefit of its implantable device in people living with heart failure.